p53 in sera for the early detection of hepatocellular carcinoma
โ Scribed by Michiie Sakamoto
- Publisher
- Springer Japan
- Year
- 2001
- Tongue
- English
- Weight
- 41 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0944-1174
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The value of various screening methods in the detection of early hepatocellular carcinoma was investigated in 95 patients with cirrhosis. Infusion hepatic angiography and computed tomography with angiography were performed yearly, ultrasound every 3 months, and determination of serum alpha-fetoprote
## BACKGROUND. Contrasting data have so far been reported on the utility and efficacy of screening patients with cirrhosis for early detection of hepatocellular carcinoma (HCC). The goal of this study was to evaluate the efficacy of a regular ultrasonographic and laboratory follow-up for the early
W e prospectively monitored 140 cirrhotic patients for the development of hepatocellular carcinoma for 6 yr, using periodical screening by high-resolution convex-array ultrasonography and a-fetoprotein. Twenty-eight patients were positive for HBs antigen, 26 patients had received blood transfusions
Human hepatocellular carcinomas from patients in Britain, an area of low prevalence of hepatocellular carcinoma and low dietary exposure to aflatoxin B,, were analyzed for mutations in the p53 tumorsuppressor gene. Abnormalities in the pS3 gene were detected in 2 of 19 hepatocellular carcinomas by p
To clarify the clinical significance of the mutation of p53 gene in hepatocellular carcinoma (HCC), 90 resected specimens from Japanese patients were assayed using a polymerase chain reaction-single strand conformation polymorphism (PCRSSCP) analysis. p53 mutations were detected in 25 cases (27.8%)